PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Premera Blue CrossCommercial · Prior Auth · Medical Policy · WA · Oncology, Hematology, Orthopedics +12 moreMedium impact

Medical Policy and Coding Updates - August 2021

Effective date
Not stated in the notice
Identified
Jun 18, 2026

Summary

This Premera medical policy and coding update lists changes from August 2021. Effective August 1, 2021, a prescription digital therapeutics policy was added, with some FDA-approved products considered investigational, and continuous glucose monitoring supplies gained quantity limits. Coding changes effective August 1 and August 6, 2021 added medical necessity or prior authorization review to codes including J2353, J2354, J1930 and T1505, and a site of service review was added for J1429. The update also lists an allograft injection for degenerative disc disease as investigational, effective November 5, 2021.

Get alerts when payers change rules like this one

We check Premera Blue Cross and other payers every day and email you when a change matches your specialty and state.

Get Premera Blue Cross alertsPolicy Monitoring is free. No card required.

What to do

Action · 6 steps
01Already effective August 6, 2021: Pharmacotherapy of Cushing's disease and acromegaly codes J2353, J2354 and J1930 now require review for medical necessity and prior authorization.
02Already effective August 6, 2021: infusion drug code J1429 now requires review for site of service.
03Already effective August 1, 2021: prescription digital therapeutic code T1505 now requires review for medical necessity, and digital breast tomosynthesis codes 77065, 77066 and 77067 now require review for medical necessity.
04Already effective August 1, 2021: codes 21685 and 42950 now require review for medical necessity, and codes 41512, 41530 and S2080 now require review for investigative care.
05Already effective November 5, 2021: allograft injection for degenerative disc disease codes 0627T, 0628T, 0629T and 0630T now require review for investigative care.
06Check current applicability rather than acting on these past dates.

Codes mentioned

J2353J2354J1930S934764451T150521685429504151241530S2080J142936516971519715397154971559715697158H0015H0017H0035S948027269L0622L0623L0624J0256A62051100877065770667706790377

Original notice

Medical Policy and Coding Updates - August 2021
premera.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account